AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Highlighted publication

Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors.

Mohammadzadeh Y, Gligorovski V, Egorova O, (…), Rahi SJ, Mansouri N, De Palma M

Science translational medicine – 2025 Dec 17

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Sara Wickström | January 29th

More information

Highlighted publication

The evolving landscape of brain metastasis: volume II.

Valiente M, Anders C, Boire A, (…), Winkler F, Zadeh G, Joyce JA

Trends in cancer – 2025 Dec 2

Events

AGORA Single-cell omics meetings | February 4th

More information

Highlighted publication

European cancer research requires renewed urgency.

Bernards R, Berns A, Joyce JA & Baumann M

Nature Cancer – 2025 Dec 1

Highlight

AGORA Scientists Rank Among World’s Top 1% Most-Cited Researchers in 2025

News

Life in Real-Time: A Conversation with Alexandre Bénéchet, Head of the IVIF Facility

Highlighted publication

Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model.

Gsell L, Watson SS, Sutevski I, (…), Cougnoux A, Joyce JA, Hausser J

iScience – 2025 Nov 21

Highlighted publication

Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma.

de Sostoa J, Marinari E, Pedard M, (…), Orend G, Dutoit V, Migliorini D

Journal for immunotherapy of cancer – 2025 Nov 4

Highlighted publication

Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapy.

Rath JA, Rudden LSP, Nouraee N, (…), Chatzi Souleiman A, Barth P, Arber C

Nature biomedical engineering – 2025 Oct 28

Highlighted publication

Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models.

Ghasemi A, Martinez-Usatorre A, Liu Y, (…), Speiser DE, Migliorini D, De Palma M

Nature Communications – 2025 Oct 15

Events

Oncology Grand Rounds, Highlights of the Year 2025 | December 19th

More information

Past news

Latest publications

Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors.

Mohammadzadeh Y, Gligorovski V, Egorova O, (…), Rahi SJ, Mansouri N, De Palma M

Science translational medicine – 2025 Dec 17

Sorafenib plus selective internal radiotherapy with (90)Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial.

Berthod G, Cisarovsky C, Petrova T, (…), Figg WD, Michielin O, Leyvraz S

British journal of cancer – 2025 Dec 11

European cancer research requires renewed urgency.

Bernards R, Berns A, Joyce JA & Baumann M

Nature Cancer – 2025 Dec 1

The evolving landscape of brain metastasis: volume II.

Valiente M, Anders C, Boire A, (…), Winkler F, Zadeh G, Joyce JA

Trends in cancer – 2025 Dec 2

Equilibrium state dynamics-based modeling of temporal dose delivery dependencies of FLASH skin sparing.

Böhlen TT, Grilj V, Sesink A, (…), Bochud F, Herrera FG, Moeckli R

Medical physics – 2025 Dec 1